Company profile
Tenax Therapeutics, Inc. Insider Trading
TENXEvery SEC Form 4 insider trading filing for Tenax Therapeutics, Inc. (TENX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0000034956
- Filings
- 35
- Insiders
- 10
- Last filing
- 2026-07-13
Activity summary
No insider transactions in the last 30 days. The most recent was on July 13, 2026, when Giordano Christopher Thomas bought 219 shares. 35 filings from 10 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q2 24 to Q3 26. Tenax Therapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $190K.
90 day insight
Over the last 90 days, Tenax Therapeutics, Inc. insiders bought $51K across 4 transactions with no open-market sales.
- Most active insider: Giordano Christopher Thomas with 4 transactions totaling $51K.
- Largest single purchase: $50K by Giordano Christopher Thomas on Jul 13, 2026.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 13, 2026 | Giordano Christopher Thomas | TENX | Option Exercise | 219 | — | — |
| Jul 13, 2026 | Giordano Christopher Thomas | TENX | Option Exercise | 8,500 | $5.94 | $50K |
| Jul 13, 2026 | Giordano Christopher Thomas | TENX | Option Exercise | 219 | $3.55 | $777 |
| Jul 13, 2026 | Giordano Christopher Thomas | TENX | Option Exercise | 8,500 | — | — |
| May 11, 2026 | Staab Thomas R II | TENX | Award | 450,000 | — | — |
44 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=TENX" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Tenax Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →